Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Interest Income Expense
Samsung Biologics Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Interest Income Expense
₩1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Interest Income Expense
-₩55.1m
|
CAGR 3-Years
54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
Interest Income Expense
₩959.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Interest Income Expense
-₩10.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Interest Income Expense
₩1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Interest Income Expense
₩5B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
39%
|
CAGR 10-Years
31%
|
See Also
What is Samsung Biologics Co Ltd's Interest Income Expense?
Interest Income Expense
1.5B
KRW
Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Interest Income Expense amounts to 1.5B KRW.